Sungjin Park
Company: Onegene Biotechnology
Job title: ceo
Seminars:
Unlocking Powerful Biology: OGB21502 is a Tetra- Specific Drug (GLP-1 X GCG X FGF21 X IL1RA) to Treat NASH & Liver Fibrosis 11:30 am
Novel protein-protein conjugation technology, which enables the facile development of multi-modalities, multi-targeting drugs Can IL-1 blocking make synergy in improving fibrosis and metabolism? Preclinical findings recommend transitioning towards the clinical stage in 2024Read more
day: Seminar A- AM tracks